NCT06745492已完成不适用
Low-dose Neostigmine at TOF Ratio of 0.7 Accelerates Neuromuscular Recovery Without Adverse Effects: a Prospective Observational Study
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 59
- 试验地点
- 1
- 主要终点
- Recovery time
研究概览
简要总结
This study is a prospective observational study. A total of 54 patients were included in this study. We observed the time from neostigmine administration to TOF ratio of 1.0.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients undergoing elective thyroid surgery under general anesthesia
- •a body mass index of 18.5-25 kg/m2
排除标准
- •Refused to participate
- •history of hypersensitivity to acetylcholinesterase inhibitor
- •neuromuscular disease
- •hepatic or renal dysfunction
结局指标
主要结局
Recovery time
时间窗: During surgery
Time from neostigmine administration to TOF ratio of 1.0
次要结局
未报告次要终点
研究者
Chang-Hoon Koo
Professor
Seoul National University Bundang Hospital
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly PatientsNeuromuscular Blockade, ResidualNCT06228092Matias Vested40
招募中
Unknown
Effect of Neostigmine (drug) in Critically ill Cirrhotics (liver disease).CTRI/2024/06/068505Institute of Liver and Biliary Sciences
已完成
1 期
Effects of Low Dose Intrathecal Neostigmine in spinal anesthesia for lower abdominal surgeryAbdominal Surgery.Lower abdominal pain, unspecifiedICD-10-CMIRCT20170429033680N6Mashhad University of Medical Sciences90
尚未招募
1 期
Study of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma/Metastatic Liver TumorsJPRN-jRCT1030220731Yamashita Hideomi36
进行中（未招募）
1 期
A blinded randomized study of two types of reversal agents (neostigmine/glycopyrrolate 50 mikrogram/kg or sugammadex 2 mg/kg) for reversal of neuromuscular blockade in elderly patients (= 75 years)Anaesthesia to laparoscopic robotassisted surgeryCTIS2023-504230-21-00Rigshospitalet1